SINGAPORE: A national laboratory that provides a realistic environment for cybersecurity research and test-bedding of solutions against cyber threats was recently launched at the National University of Singapore (NUS).

The National Cybersecurity Research and Development (R&D) Laboratory costs S$8.4 million which was funded by the National Research Foundation (NRF), and it is capable of simulating the performance of more than a thousand computers to perform tasks like emulating large-scale malicious cyber attacks. It also houses a large collection of malware for research and education purposes.

Cybersecurity

 

Research institutions and industry players have already tapped on the lab's infrastructure to work on about 20 projects, which span areas such as software security improvements and cloud data storage safeguards.

NRF director of programmes George Loh said the facility enabled experiments that were "complex, scalable and relevant to Singapore" to be demonstrated in a reliable testbed. "This will facilitate innovation and translation of R&D capabilities in Singapore into solutions that can be deployed globally, helping to strengthen Singapore's position as a cybersecurity R&D hub," he added.

NUS and NRF also teamed up with local telco Singtel to launch a corporate cybersecurity lab in October last year, with the three parties pledging to pump S$43 million into the project over the next five years.

Essex,UK - Following on from an earlier overview of tech. growth at KAO Park in Harlow, Essex we can also report on R & D activity at Chesterford Research Park which affirms Essex’s contribution to the Cambridge life sciences cluster.

Located in Essex but just 15 miles from Cambridge, Chesterford Research Park is an integral part of the Cambridge biotech cluster. The park is home to innovative companies including Isogenica and Charles River Laboratories, and is a key site within the wider UK life sciences ‘golden triangle’ (London-Cambridge-Oxford), contributing to its impressive track record of technology development and ground-breaking scientific discoveries.

A LEADING CENTRE FOR BIOTECH INNOVATION

Many of the businesses at Chesterford Research Park are leaders in their fields. AstraZeneca undertakes research and development on the site alongside other high-profile biotech companies, many of which are spinouts from Cambridge University. Cellcentric (discovery of small molecule cancer inhibitors), Isogenica (biologics drug development) and Isomerase Therapeutics (biosynthetic engineering) are all involved in highly specialised drug discovery and development. Oncologica has developed precision oncology testing enabling targeted cancer therapies and Axol Bioscience creates human cell cultures and reagents for research. 

ACCESSING ‘TOP TALENT’ WITHIN THE CAMBRIDGE CLUSTEr

When, in 2013, Astra Zeneca announced plans to relocate major UK R&D operations from Cheshire to Cambridge, the company cited “access to world-class talent and opportunities for collaboration”as key drivers behind the move]. Within the Cambridge Cluster, the same advantages are attracting leading businesses to Chesterford Research Park, and Essex.

Arecor, a leader in formulation technology innovation, is currently in the process of relocating to Chesterford. Their CEO, Dr. Sarah Howell said, “We selected Chesterford because of the quality of innovative companies already located here, the Park’s location within the Cambridge cluster and the excellent central facilities.  Attracting top talent as we continue to grow is key to our future success and we feel that Chesterford is the ideal location from which we can continue to forge ahead.”

MEETING THE NEEDS OF GROWING LIFE SCIENCES COMPANIES

One of Chesterford’s key advantages is its ability to meet the changing accommodation needs of growing life sciences companies on a single site. Chesterford Science Village provides small-scale laboratory and office spaces for early-stage start-up firms, which can then expand by taking on more space in the same location. This flexibility has attracted companies such as the award-winning DRW to the site. A producer of novel point-of-care diagnostic kits, DRW has expanded at Chesterford from start-up to established business.

Chesterford Research Park also provides space for larger businesses. Domainex, a provider of integrated drug discovery services, recently moved into an existing building on the park, having out-grown accommodation at Cambridge Science Park. Companies including Charles River Laboratories and AstraZeneca have designed and built their own bespoke buildings on the site, which still offers space for further business expansions.

Chesterfordresearchparkessex

Chesterford Research Park

CLOSE TO CAMBRIDGE, WITH SPACE FOR GROWTH

The Cambridge Cluster’s excellence in life sciences continues to attract the best companies and talent. But within the city of Cambridge, it’s not easy for businesses to find space for growth. Just a few miles away, in Essex, Chesterford Research Park provides that space, along with all the other advantages of the Cambridge Cluster.

Contact www.investessex.co.uk  to find out more about the Essex UK Health Technology Cluster

FRIEDRICHSHAFEN, GERMANY/PUNE: German automotive components manufacturer ZF Friedrichshafen AG is setting up its first ever India Technology Center in Hyderabad which will be dedicated to software and mechanical engineering.

The new Technology Centre will support ZF's global development teams while enabling the company to accelerate local product development.

Stefan Sommer, CEO of ZF Friedrichshafen AG said "This new facility is a significant investment for ZF in India. We are harnessing the skilled talent pool that India has to offer in order to develop superior technology solutions for our global as well as local customers". Over the years, ZF has been successful in localizing high technology products in India.

“As demand for software engineering grows, we will exponentially increase our capacity to help meet our customers' growth aspirations. With this Technology Centre, we are reinforcing our global R&D footprint as well as our commitment and investment in the rapidly emerging Indian market," he added.

13,800 engineers are currently working in R&D with ZF globally. The research and development network consists of more than 100 development locations, including 17 main development locations. ZF's first Technology Centre in India will be fully operational by January 1, 2017 and is expected to have a work force of 2,500 engineers by 2020.

ZF has made considerable investments and advanced technology launches in the Indian market for example in its Pune facility, the first launch of the Electric Park Brake (EPB) technology in India and also inaugurated ZF Hero Chassis systems, a 50-50 JV ZF India Pvt. Ltd. and Hero Motors Ltd in Oragadam, Kanchipuram district.

BrakeDisc

ZF has been operating for more than three decades in the Indian market and ZF TRW for more than 50 years through its joint venture with TVS and Rane groups. Currently with about 12,000 employees including JV's, ZF has 19 production facilities excluding warehouses and office buildings.

Mamatha Chamarthi, senior vice president and executive lead for the new India Technology Center said "ZF has an impressive history of being the leader and innovator in the auto component sector. We have 1,000 external engineers in the field of electronics, software and mechanical engineering with key Indian Engineering Services providers in Pune, Bangalore and Hyderabad. Our ZF India Technology will build on this engineering foundation, and focus not only on bringing advanced technology to India, but localizing more strategic business activities including research, design and development."

ZFZF

Dünya, Turkey – Germany’s Siemens, a global industrial production, energy and healthcare company, is spending EUR 30 million on building a tram factory in the Gebze district of Kocaeli near Istanbul.

Not only will trams made at the plant be sold here but Siemens’ transportation division will also utilize the country’s strategic location to access nearby markets, including several in Europe.

siemensturkey

“Siemens trams are chosen for the light rail systems of many countries and will be exported from Turkey. We aim to have a localization ratio of 50 percent for the trams to be manufactured in the Gebze plant by relying on local suppliers,” said Siemens Turkey’s transportation unit head, Cüneyt Genç.

The Gebze factory will become operational in 2017, initially employing 300 people. Production will start at 100 trams per year, which can be expanded to meet demand and make new models, according to Genç. Siemens also plans to invest in an R&D center to accompany the tram plant to develop and engineer mobility solutions.

As part of its nation-wide transportation upgrade program, the Turkish government plans to acquire billions of euros worth of light rail sets for urban transportation in the coming years.

The country will also invest heavily in its railways, increasing the length of tracks to 26,000 kilometres – nearly double the current 12,000 kilometres – of which high-speed lines will make up 10,000 kilometres.

A tender for the acquisition of 80 high-speed train sets, which is being closely followed by global rail companies including Siemens, is expected to take place this year.

More Articles ...

Search Information & Analysis...

RSS Feed:

  • Reuters: Business News Sep 26, 2017 | 00:58 am

    TOKYO (Reuters) - Asian shares slumped on Tuesday while the[…]

  • Reuters: Business News Sep 26, 2017 | 00:19 am

    SYRACUSE, N.Y./GRAND RAPIDS, Mich. (Reuters) - A debate within the[…]

  • Reuters: Technology News Sep 25, 2017 | 23:50 pm

    SAN FRANCISCO (Reuters) - Shares of Apple Inc dipped on[…]

  • Reuters: Business News Sep 25, 2017 | 23:26 pm

    LONDON (Reuters) - Boeing Co has opened a program office[…]

  • Reuters: Business News Sep 25, 2017 | 22:39 pm

    WASHINGTON/SAN FRANCISCO (Reuters) - Hackers breached the U.S. Securities and[…]